Metraipolis › archive › dc_97a994cb462b

Trends and variation in the use of andexanet alfa for the reversal of direct oral anticoagulants in NHS trusts in England — Europe PMC PMID:41406988

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41406988
DOI
10.1002/bcp.70417
License (as archived)
solo-consultazione
Archived
2026-11-07T14:26:55.252Z
SHA-256 of the archived text
29f2e5c0fa4aa870a3e88a4231f9968926b3fc22b3ed1d9adac795b8a52ebf96
Stable URL of this page
https://metraipolis.com/documento/dc_97a994cb462b

How to cite

Trends and variation in the use of andexanet alfa for the reversal of direct oral anticoagulants in NHS trusts in England — Europe PMC PMID:41406988 — Europe PMC (en), https://europepmc.org/article/MED/41406988 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_97a994cb462b (Metraipolis archive dc_97a994cb462b, sha256 29f2e5c0fa4aa870a3e88a4231f9968926b3fc22b3ed1d9adac795b8a52ebf96)
BibTeX
@misc{dc97a994cb462b,
  title = {Trends and variation in the use of andexanet alfa for the reversal of direct oral anticoagulants in NHS trusts in England — Europe PMC PMID:41406988},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41406988},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_97a994cb462b; sha256 29f2e5c0fa4aa870a3e88a4231f9968926b3fc22b3ed1d9adac795b8a52ebf96},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41406988. Agents can read the archived copy with the MCP tool read_document.